BIT
SGNT

BlackRock Institutional Trust’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

BlackRock Institutional Trust’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-831,695
Closed -$12.5M – 3964
2016
Q2 		$12.5M Buy
831,695
+224,004
+37% +$2.88M ﹤0.01% 2153
2016
Q1 		$7.4M Buy
607,691
+7,785
+1% +$109K ﹤0.01% 2464
2015
Q4 		$9.54M Buy
599,906
+13,561
+2% +$213K ﹤0.01% 2353
2015
Q3 		$8.99M Buy
586,345
+151,530
+35% +$3.28M ﹤0.01% 2363
2015
Q2 		$10.6M Buy
434,815
+67,800
+18% +$1.62M ﹤0.01% 2375
2015
Q1 		$8.53M Buy
367,015
+54,646
+17% +$1.45M ﹤0.01% 2493
2014
Q4 		$7.84M Buy
312,369
+76,699
+33% +$2.25M ﹤0.01% 2506
2014
Q3 		$7.33M Sell
235,670
-24,313
-9% -$659K ﹤0.01% 2498
2014
Q2 		$6.72M Sell
259,983
-8,845
-3% -$196K ﹤0.01% 2635
2014
Q1 		$6.28M Buy
268,828
+29,918
+13% +$654K ﹤0.01% 2685
2013
Q4 		$6.06M Sell
238,910
-16,700
-7% -$377K ﹤0.01% 2695
2013
Q3 		$5.21M Buy
255,610
+36,345
+17% +$809K ﹤0.01% 2714
2013
Q2 		$4.6M Buy
+219,265
New +$3.92M ﹤0.01% 2741

BlackRock Institutional Trust's SGNT Position: Q3 2016 in Review

BlackRock Institutional Trust sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 831,695 shares — an estimated $12.5M sold.

BlackRock Institutional Trust first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $12.5M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • BlackRock Institutional Trust reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 831,695 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $12.5M.
  • BlackRock Institutional Trust first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • BlackRock Institutional Trust's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $12.5M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on BlackRock Institutional Trust's 13F filing for Q3 2016, filed 8 Nov 2016.